Article Text

Download PDFPDF
Expression of matrix metalloproteinase-2 and mutant p53 is increased in hydatidiform mole as compared with normal placenta
  1. P. Petignat*,,
  2. R. Laurini,
  3. F. Goffin§,
  4. I. Bruchim and
  5. P. Bischof*
  1. *Department of Obstetrics and Gynecology, Hormone Laboratory, University of Geneva, Geneva, Switzerland
  2. Department of Obstetrics and Gynecology, Gynecologic Oncology and Senology Unit, Geneva University Hospitals, Geneva, Switzerland
  3. Department of Gynecology and Obstetrics, University Hospital Lund, Developmental Pathology, Lund, Sweden
  4. §Department of Gynecology and Obstetrics, University of Liege, Liege, Belgium
  5. Gynecologic Oncology Service, McGill University, Montreal, Canada
  1. Address correspondence and reprint requests to: Patrick Petignat, MD, CHUM – Notre-Dame, 1560, Sherbrooke Est., Montréal H2L 4M1, QC, Canada. Email: patrick.petignat.chum{at}ssss.gouv.qc.ca

Abstract

Matrix metalloproteinases (MMPs) are group of enzymes thought to play an important role in trophoblastic and tumor invasion. The aim of our study was to investigate the trophoblastic expression of MMPs and p53 in normal trophoblast and hydatidiform moles (HM). Paraffin sections of 45 specimens, including 14 complete hydatidiform moles (CM), 15 partial hydatidiform moles (PM), 8 atypical partial hydatidiform moles (aPM), and 8 controls were selected. Classification of HM was established on histologic criteria and supported by the DNA ploidy results. Tissue sections from each case were immunostained with monoclonal antibodies, cytokeratin-7, MMP-2, MMP-9, tissue inhibitors of metalloproteinases (TIMP)-1, and p53 wild type (p53wt) and mutant types (mutp53). Staining for cytokeratin-7 revealed a positive reaction in 93% of the samples. MMP-2 was mainly expressed in the syncytiotrophoblast of HM and found in 62% of aPM, 60% PM, and 93% CM. The mutp53 was mainly and focally expressed in syncytiotrophoblastic cells and was found in 63% of aPM, 80% PM, and 93% CM. Expression of MMP-2 and mutp53 was both significantly greater in HM vs control group (P < 0.05) and greater in CM vs PM and aPM (P < 0.05). No significant difference was observed for cytokeratin-7, MMP-9, TIMP-1, and p53wt between the HM subgroups and between HM and control group. MMP-2 and mutp53 are overexpressed in HM as compared with normal trophoblast and might participate in the invasive behavior of the HM.

  • hydatidiform mole
  • MMP
  • p53
  • TIMP
  • trophoblastic disease

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.